American Heart Association's Health Tech Competition Crowns Innovation Winners at Scientific Sessions 2026
Found this article helpful?
Share it with your network and spread the knowledge!

The American Heart Association (AHA) announced the winners of its Health Tech Competition at Scientific Sessions 2026, held Nov. 7-8 at McCormick Place in Chicago. The competition, hosted by the AHA Center for Health Technology & Innovation, drew a record number of submissions from health technology companies worldwide, underscoring the growing interest in developing solutions for cardiovascular and brain health. After a rigorous multi-stage review by AHA volunteer experts, five finalists were selected, with two companies taking top honors for their potential to improve patient care.
MedRhythms, based in Portland, Maine, received the Best Business, Audience Choice, and Best Overall awards for its digital health and neurotherapeutics solution. The technology combines sensors, software, and music to help people improve walking and mobility after stroke or other neurological injury or disease. The at-home, prescription therapy uses foot-worn sensors to track walking and adjusts music rhythm to guide steps, with the goal of improving walking speed and quality. "Millions of people are living with walking difficulties after stroke, yet many have limited access to effective rehabilitation once they leave the clinic," said Brian Harris, founder and CEO of MedRhythms. "This recognition helps raise awareness of the need stroke patients face and supports broader access for patients who could benefit."
Vascudyne, based in St. Paul, Minn., won the Best Science award for its bioengineered blood vessel technology. The company is developing ready-to-use grafts for heart surgery that could reduce the need to harvest a vein from a patient's leg for bypass surgery and provide a conduit for children with congenital heart defects that has the potential to grow with them. The technology uses human donor cells to grow tissue, leaving behind a collagen framework that, after implantation, allows the patient's own cells to populate it. "Heart surgeons have always had to choose between living tissue harvested from the patient and off-the-shelf materials that can't heal or grow," said Zeeshan Syedain, PhD, CEO and co-inventor of Vascudyne. "Our bioengineered vessel is both."
The other finalists were HEARTio (Pittsburgh, Pa.), MEGI (Chicago, Ill.), and Seerlinq (Bratislava, Slovakia). Their technologies ranged from AI-powered ECG analysis to digital platforms for women's heart health and non-invasive cardiac pressure monitoring. The competition's record submissions and the quality of the finalists reflect the AHA's commitment to accelerating innovation in cardiovascular and brain health. "The Health Tech Competition gives us a close look at technologies designed around real challenges facing patients and clinicians," said Lee Shapiro, chairman of the board of the AHA. "This year's winners demonstrated the attributes essential to advancing health technology: strong scientific evidence, meaningful business potential and innovative ways to address the challenges of those in need."
For Texas, the competition highlights the state's growing role in health technology innovation. The AHA, based in Dallas, continues to foster an ecosystem that supports entrepreneurs and researchers working on solutions that can have global impact. The recognition of companies like MedRhythms and Vascudyne, along with finalists such as HEARTio and MEGI, signals a promising future for health tech that can improve outcomes for patients with cardiovascular and brain conditions. More information about the competition is available at ahahealthtech.org/aha-health-tech-competition-2026.
The AHA's Scientific Sessions is a premier global event for cardiovascular science, and the Health Tech Competition serves as a platform to bridge the gap between innovation and real-world care. As these technologies advance, they could significantly impact how cardiovascular and brain health conditions are prevented, diagnosed, and treated, ultimately improving lives. For more details on the finalists, see the AHA news release Health tech competition finalists advance solutions for heart and brain health. To learn more about the AHA's mission, visit heart.org and stroke.org.
